does pfizer make a glp-1 Understanding Drugs: Cost, Safety, and Access in Context Oral GLP-1 Medication Helps Patients

An earlier Clinical Practice Guidance joint statement made in October 2024 by multiple medical societies (American Society of Anesthesiologists (ASA), American Gastroenterological Association, American Society for Metabolic and Bariatric Surgery, International Society of Perioperative Care of Patients with Obesity, and the Society of American Gastrointestinal and Endoscopic Surgeons) states that most patients should continue taking their GLP-1 drugs before elective surgery

The ASMBS 2022 guidelines acknowledge that anti-obesity medications (AOMs) represent a valuable tool in the comprehensive management of post-bariatric weight regain, though evidence remains limited compared to primary obesity treatment

GLP-1 drugs seem to work more diffusely, nudging the system rather than cutting off a single route

Published online April 22, 2024